Physical Therapists in Mansura, LA Accepting Medicare
7 Physical Therapists found. Showing 1 - 7
 Hunter S Christ, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7680 |
 Lemoine Therapy Services Of Cenla Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 7406 Highway 1, Suite 102, Mansura, LA 71350 Phone: 318-240-7680 Fax: 318-240-7681 |
Jordan J Theriot, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7680 Fax: 318-240-7681 |
Austin T Dufrene, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7680 Fax: 318-240-7681 |
Michael D Wilson, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7680 Fax: 318-240-7681 |
 Mylaina N Gary, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7680 Fax: 318-240-7681 |
Scott A Mcbride, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7680 Fax: 318-240-7681 |
News Archive
Reports showcase potential of scientists working together to find breast cancer predictors
Two new reports issuing in Science Translational Medicine today showcase the potential of teams of scientists working together to solve increasingly complex medical problems.
IMIX, Arcoma announce intended merger
IMIX, an end-user provider of superior digital radiography (DR) systems, and Arcoma, a leading supplier of medical radiology systems and sub-systems, announce a letter-of-intent to combine the two companies into a single holding company, IMIX Holding AB. The proposed combination will allow both companies to offer a comprehensive line of leading radiology systems and sub-systems to markets and customers around the world.
Nanotechnology and COVID-19 diagnosis and treatment
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Columbia closes sale of progesterone related assets and 11.2M shares to Watson
Columbia Laboratories, Inc. announced today that it has closed the sale of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc.. Columbia's business now consists of its royalty and manufacturing revenues, potential milestone payments, its collaboration with Watson on the development of next-generation progesterone products, and its novel bioadhesive drug delivery technologies and other products.
Scientists identify central switch responsible for epilepsy
UC Irvine and French researchers have identified a central switch responsible for the transformation of healthy brain cells into epileptic ones, opening the way to both treat and prevent temporal lobe epilepsy.
› Verified 7 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists